VANCOUVER, BRITISH COLUMBIA--(Marketwire - February 29, 2008) - Pacgen Biopharmaceuticals Corporation (“Pacgen”) (TSX VENTURE: PGA) today reported financial results from its third fiscal quarter ended December 31, 2007. Amounts unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP).
